论文部分内容阅读
分析1961～1970年所治疗的118例声门上癌,其中89例曾经随访,作为疗效分析资料。 50例用放射治疗,钴剂量为6500R。31例用手术治疗,其中3例仅作全喉切除及颈廓清术。8例为放射、手术综合治疗(在3个月内进行)。据作者经验,声门上癌如无颈淋巴结转移,不论肿瘤的大小,原用放射治疗或手术治疗,其绝对3年存活率为73％。有颈淋巴结转移,原用放射治疗,绝对3年存活率为6％,这些病例一般肿瘤较大,有颈淋巴结转移;原用手术治疗者,绝对3年存活率为23％,此种病人的肿瘤均较小。
Analysis of 118 cases of supraglottic cancer treated from 1961 to 1970, of which 89 cases have been followed up, as a data analysis of efficacy. 50 patients were treated with radiation and the cobalt dose was 6500R. Thirty-one patients were treated with surgery. Three of them had only complete laryngectomy and neck dissection. Eight patients received radiotherapy and surgery (within 3 months). According to the author’s experience, if there is no cervical lymph node metastasis on the glottis, regardless of the size of the tumor, the absolute three-year survival rate was 73% regardless of whether the patient had been treated with radiation or surgery. With cervical lymph node metastases, the original three-year survival rate was 6%. These cases were generally larger and had cervical lymph node metastases. The absolute 3-year survival rate was 23% for patients who had undergone surgery. The tumors are small.